Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVersarien Regulatory News (VRS)

Share Price Information for Versarien (VRS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.105
Bid: 0.10
Ask: 0.105
Change: -0.002 (-1.91%)
Spread: 0.005 (5.00%)
Open: 0.1005
High: 0.105
Low: 0.1005
Prev. Close: 0.1045
VRS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Exercise of Options

7 Dec 2017 07:00

RNS Number : 6262Y
Versarien PLC
07 December 2017
 

7 December 2017

Versarien plc

("Versarien" or the "Company")

Exercise of Options

Director/PDMR Shareholding

Versarien plc (AIM: VRS), the advanced materials engineering group, announces it has issued 910,900 ordinary shares of 1 pence each in the Company ("Ordinary Shares") following the exercise by directors and an employee of the Company under the Company's share option schemes.

Named person

No. options exercised

Exercise price per share

Neill Ricketts

250,000

12.25p

Chris Leigh

528,720

15.50p

Employee (non-PDMR)

132,180

12.25p

Total

910,900

 

 

Application has been made for the new Ordinary Shares to be admitted to trading on AIM, which is expected to take place on 11 December 2017. The new Ordinary Shares will rank, pari passu, with the existing Ordinary Shares in issue.

The Company was also notified that Christopher Leigh, Chief Financial Officer has sold 528,720 Ordinary Shares at an average price of 73.81 pence per Ordinary Share.

Following the transactions outlined above:

Mr Ricketts' interest in the share capital of the Company has increased to a total of 15,625,000 Ordinary Shares representing 10.53 per cent. of the Company's issued share capital enlarged pursuant to the exercise of options. Mr Ricketts is further interested in 278,720 options exercisable at 12.25 pence per share together with 2,626,614 options exercisable at 15 pence per share and 1,050,761 options exercisable at 29 pence per share; and

Mr Leigh's interest in the share capital of the Company has remained at a total of 315,000 Ordinary Shares representing 0.21 per cent. of the Company's issued share capital enlarged pursuant to the exercise of options. Mr Leigh is further interested in 2,626,614 options exercisable at 15 pence per share and 1,050,761 options exercisable at 29 pence per share.

Total Voting Rights

Following the issue of the new Ordinary Shares, the Company will have 148,386,309 ordinary shares of 1 pence each in issue. No Ordinary Shares are held in treasury. The figure of 148,386,309 may be used by the Company's shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

Enquiries:

Versarien 01242 269 122

Neill Ricketts, CEO

Chris Leigh, CFO

WH Ireland (Nominated Advisor) 0117 945 3470

Mike Coe / Ed Allsopp

IFC Advisory (Financial PR and IR) 0203 053 8671

Tim Metcalfe

Graham Herring

Heather Armstrong

 

The information below, set out in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Neill Ricketts

2

Reason for the notification

a)

Position/status

Chief Executive Officer

b)

Initial notification/ Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Versarien plc

b)

LEI

213800D6NZED7V8W2Z34

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 1p each

 

GB00B8YZTJ80

b)

Nature of the transaction

Exercise of options

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

12.25p

250,000

 

d)

Aggregated information

- Aggregated volume

- Price

 

250,000

£30,625

e)

Date of the transaction

5 December 2017

f)

Place of the transaction

London Stock Exchange, AIM

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Christopher Leigh

2

Reason for the notification

a)

Position/status

Chief Financial Officer

b)

Initial notification/ Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Versarien plc

b)

LEI

213800D6NZED7V8W2Z34

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 1p each

 

GB00B8YZTJ80

b)

Nature of the transaction

Exercise and sale of options

c)

Price(s) and volume(s)

Exercise:

Price(s)

Volume(s)

15.50p

528,720

 

Sale:

Price(s)

Volume(s)

74.00p

73.64p

250,000

278,720

 

d)

Aggregated information

- Aggregated volume

- Price

 

- Aggregated volume

- Price

 Exercise:

528,720

£81,952

Sale:

528,720

£390,249

e)

Date of the transaction

5 December 2017

f)

Place of the transaction

London Stock Exchange, AIM

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHOKADPCBDDQBK
Date   Source Headline
1st Dec 20224:41 pmRNSSecond Price Monitoring Extn
1st Dec 20224:35 pmRNSPrice Monitoring Extension
2nd Nov 20224:35 pmRNSPrice Monitoring Extension
30th Sep 202212:48 pmRNSResult of AGM
28th Sep 20224:41 pmRNSSecond Price Monitoring Extn
28th Sep 20224:36 pmRNSPrice Monitoring Extension
26th Sep 20227:00 amRNSBiaBrazil to utilise Graphene-Wear Technology
24th Aug 20227:00 amRNSNotice of AGM
30th Jun 20227:00 amRNSVerified Graphene Producer Re-certification
27th Jun 20227:00 amRNSLaunch of New Superparamagnetic Material
12th May 20227:00 amRNSInterim Results
10th May 20227:00 amRNSUmbro to Utilise Versarien’s Graphene-Wear Tech
3rd May 20227:00 amRNSNotice of Results and Investor Presentation
25th Apr 20223:25 pmRNSHolding(s) in Company
9th Mar 20227:00 amRNSLaunch of Lunar 3D printed lifestyle pods
24th Feb 20227:00 amRNSChange of Auditors and Accounting Reference Date
22nd Feb 20227:00 amRNSFlux Footwear to launch graphene enhanced shoe
20th Jan 20227:00 amRNSInvestor Event
4th Jan 20227:00 amRNSConfirmation of Board Change
24th Dec 20217:00 amRNSHolding(s) in Company
10th Dec 20217:00 amRNSInvestor Presentation
6th Dec 20217:00 amRNSInterim Results
2nd Dec 20217:00 amRNSNotice of Results and Investor Presentation
17th Nov 20212:27 pmRNSHolding(s) in Company
16th Nov 202112:31 pmRNSSuperdry partners with Versarien
11th Nov 20217:00 amRNSInvestor Presentation
1st Nov 20217:00 amRNSConsortium wins Department for Transport backing
29th Oct 20211:41 pmRNSResponse to Media Speculation
29th Oct 20217:00 amRNSInvestor Presentation
13th Oct 20217:00 amRNSAppointment of Non-executive Chairman
23rd Sep 20212:08 pmRNSResult of AGM
2nd Sep 202111:01 amRNSChange of Registered Address
27th Aug 20211:54 pmRNSNotice of AGM and Posting of Annual Report
11th Aug 20219:53 amRNSHolding(s) in Company
5th Aug 20217:00 amRNSPreliminary Results
30th Apr 20217:00 amRNSTotal Voting Rights
9th Apr 20217:00 amRNS£1.93m strategic investment by Graphene Lab
26th Feb 202110:16 amRNSInnovate UK Loan
9th Feb 20217:00 amRNSGraphene Enhanced Mask Update
22nd Jan 202111:05 amRNSDirector/PDMR Shareholding
21st Jan 20217:00 amRNSInterim Results
7th Jan 20217:00 amRNSAppointment of Chief Technology Officer
31st Dec 20207:00 amRNSTotal Voting Rights
30th Dec 20207:00 amRNSHolding(s) in Company
23rd Dec 202012:31 pmRNSHolding(s) in Company
22nd Dec 20207:00 amRNSAcquisition, Subscription & Sharing Agreement
24th Nov 20207:00 amRNS£1.95 million Development Agreement
23rd Nov 20204:39 pmRNSInterim Results Reporting Extension
18th Nov 20207:00 amRNSSARS-CoV-2 Inhibition by Graphene / Metal Oxides
21st Oct 202012:00 pmRNSResult of GM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.